| 5-R01-EB032321-03 |
Biocompatible triarylmethyl radical-based dendrimers as nonmetallic contrast agents for MRI |
Benoit Driesschaert |
West Virginia University |
| 1-R01-EB033919-01A1 |
Bioengineering probiotic bacterium contrast agents for monitoring of inflammation using multispectral optoacoustic tomography |
Jorge Gomez-Gutierrez |
University of Missouri-Columbia |
| 5-T32-EB027629-05 |
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM) |
Tzung Hsiai |
University of California Los Angeles |
| 5-R21-EB032495-02 |
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development |
Matthew Parker |
State University New York Stony Brook |
| 5-R21-EB028425-03 |
Chemical tools to decode nuclear lamina-ome |
Bingbing Li |
Oregon Health & Science University |
| 5-R21-EB030071-04 |
Cherenkov luminescence mediated excitation of discrete lanthanide optical probes |
Eszter Boros |
University of Wisconsin-Madison |
| 5-R01-EB028858-04 |
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC |
Andrew Tsourkas |
University of Pennsylvania |
| 5-R01-EB021155-08 |
Copper-mediated Radiofluorination: from Proof-of-Concept to Clinical Impact |
Peter Scott |
University of Michigan at Ann Arbor |
| 1-DP2-EB037187-01 |
Deep-tissue targeted molecular imaging with a palette of NIR-II emissive DNA-stabilized nanoclusters |
Stacy Copp |
University of California-Irvine |
| 5-R01-EB029429-04 |
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications |
Michael Evans |
University of California, San Francisco |
